Glenview Capital Management
Glenview Capital Management reported 135 stocks worth $5.6B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are GPN (10.3%), THC (9.3%) and AMZN (6.6%). Compared with Q2 2026, the fund opened new positions in TEVA, SGRY and MRVL, added to AMZN, META and AMD, trimmed GPN, THC and TMO and sold out of DKS, FUN and STM.
Latest filing: what Glenview Capital Management did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() GPN Global Pmts Inc | $580M | 10.3% | 7.1M | −1.8M (−20%) | 8 of 8 | |
| 2 | ![]() THC Tenet Healthcare Corp | $523M | 9.3% | 2M | −188K (−8%) | 8 of 8 | |
| 3 | ![]() AMZN Amazon Com Inc | $373M | 6.6% | 1.5M | +224K (+18%) | 8 of 8 | |
| 4 | ![]() META Meta Platforms Inc | $359M | 6.4% | 495K | +138K (+39%) | 7 of 8 | |
| 5 | ![]() TMO Thermo Fisher Scientific Inc | $300M | 5.3% | 444K | −183K (−29%) | 6 of 8 | |
| 6 | ![]() TEVA Teva Pharmaceutical Industries Ltd | $300M | 5.3% | 7.6M | New position | 1 of 8 | |
| 7 | ![]() A Agilent Technologies Inc | $257M | 4.6% | 1.5M | −475K (−24%) | 2 of 8 | |
| 8 | ![]() AMD Advanced Micro Devices Inc | $239M | 4.3% | 391K | +93K (+31%) | 4 of 8 | |
| 9 | ![]() DHR Danaher Corp | $234M | 4.2% | 1.1M | −88K (−8%) | 6 of 8 | |
| 10 | ![]() HUM Humana Inc | $208M | 3.7% | 545K | +291K (+115%) | 3 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
TEVA PHARMACEUTICAL INDS LTD | $172M | 5.1M |
![]() DKS Dicks Sporting Goods Inc | $91M | 401K |
![]() FUN Six Flags Entertainment Corp | $43M | 2M |
![]() STM Stmicroelectronics N V | $41.9M | 560K |
![]() BKR Baker Hughes Co. A | $27.4M | 494K |
🔒 Free account: see all 9.
Options
valued at the underlying sharesReported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Glenview Capital Management 13F FAQ
What does Glenview Capital Management own?
Glenview Capital Management reported 135 stocks worth $5.6B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are GPN (10.3%), THC (9.3%) and AMZN (6.6%). The table above lists every position in the filing (the top 10 without an account).
What did Glenview Capital Management buy and sell in Q3 2026?
Compared with Q2 2026: 102 new positions, 16 added to, 15 trimmed and 9 sold out. New positions include TEVA, SGRY and MRVL. It sold all of DKS, FUN and STM.
When will Glenview Capital Management file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Glenview Capital Management's portfolio worth?
The Q3 2026 filing reports $5.6B in US stocks ($6.1B including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.
























